Valuation dashboard for SOPHiA GENETICS S.A. (SOPH) with P/E N/A, P/B 7.33, EV/EBITDA -9.10 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe.
Analysis Summary
SOPHiA GENETICS S.A. reported revenue of $77.3M in the most recent fiscal year, growing at a 5-year CAGR of 22.2%.
Trailing-twelve-month margins: gross margin 66.6%, operating margin -85.0%, net margin -93.9%.
At the current price of $7.97, SOPH has negative trailing earnings (P/E not meaningful) and an ROE of -136.71%. Market capitalisation stands at $669M.
Balance sheet quality for SOPH: current ratio of 2.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 7.33 |
| EV / EBITDA | -9.10 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-23.33 |
| vs Current Price | -392.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SOPH | SOPHiA GENETICS S.A. | $669M | 7.33 | -136.7% | |
| TEM | Tempus AI, Inc. | $12.3B | 22.79 | -49.9% | |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.5B | 41.59 | 5.98 | |
| HQY | HealthEquity, Inc. | $8.1B | 34.54 | 4.05 | |
| HNGE | Hinge Health, Inc. | $7.3B | |||
| WAY | Waystar Holding Corp. | $5.1B | 34.57 | 1.20 | 3.6% |
| DOCS | Doximity, Inc. | $4.8B | 29.31 | 5.20 | |
| HTFL | Heartflow, Inc. Common Stock | $4.2B | 14.82 | -42.3% |
Price
| Price | $7.97 |
| Market Cap | $669M |
| Exchange | NASDAQ |
| Country | CH |
Profitability
| Return on Equity | -136.71% |
| Return on Invested Capital | -48.83% |
| Return on Assets | -40.77% |
| Gross Margin | 66.63% |
| Operating Margin | -85.01% |
| Net Margin | -93.86% |
Related companies: ACIU · AGL · ANRO · CLLS · DH · LRMR · NAKA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of SOPH: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks